Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06085716 · ClinicalTrials.gov registry record · Phase 2
Combination Therapy for Cancer Related Fatigue in Patients With Metastatic Cancers
A Phase 2 study of Fatigue and Metastatic Cancers, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 240
- Enrollment target
- 1
- Study location
NCT06085716 is a Phase 2 study of Fatigue and Metastatic Cancers that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 240 participants, above the 216-participant average among 109 other Fatigue trials with a reported enrollment target (11% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06085716, a Phase 2 study of Fatigue and Metastatic Cancers, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
To find out if combining psychoeducational interventions (such as education, counseling, and self-managed therapies) with an open-label placebo can help to improve your quality of life better than either the psychoeducational interventions or the placebo alone.
Conditions Studied
Interventions
- BEHAVIORAL Psychoeducational Intervention
- DRUG Open Label Placebo
- BEHAVIORAL Psychoeducational Intervention+Placebo
Study Locations (1)
Texas
- MD Anderson Cancer Centerr - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2024-02-16 |
| Est. Completion | 2029-08-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06085716
The ClinicalTrials.gov registry entry for NCT06085716 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 216-participant average among 109 other Fatigue trials with a reported enrollment target (11% higher). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Fatigue appearing as the primary indexed condition, and to 3 interventions - of which Psychoeducational Intervention is the first listed.
NCT06085716 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06085716 about?
NCT06085716 is a clinical study titled "Combination Therapy for Cancer Related Fatigue in Patients With Metastatic Cancers". To find out if combining psychoeducational interventions (such as education, counseling, and self-managed therapies) with an open-label placebo can help to improve your quality of life better than either the psychoeducational interventions or the placebo alone.
What is the current status of trial NCT06085716?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 240 participants. The study started on 2024-02-16. Estimated completion is 2029-08-31.
What conditions does trial NCT06085716 study?
This clinical trial studies the following conditions: Fatigue, Metastatic Cancers.
What interventions are being tested in trial NCT06085716?
The interventions under investigation include: Psychoeducational Intervention (BEHAVIORAL), Open Label Placebo (DRUG), Psychoeducational Intervention+Placebo (BEHAVIORAL).
Who is sponsoring clinical trial NCT06085716?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06085716 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fatigue
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
RECRUITING · Phase 2
-
Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency
RECRUITING · Phase 2
-
Take the Reins: The Effects of Nutrient Timing on Cancer-related Fatigue
RECRUITING · Phase 2
-
Clinical Trial of the Seaweed Supplement Fucoidan in Survivors of Cancer
RECRUITING · Phase 2
-
Transcranial Direct Current Stimulation for Post-stroke Fatigue
RECRUITING · Phase 2
-
Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.